Annual CFI
$4.22 M
+$4.40 M+2393.74%
31 December 2023
Summary:
Qualigen Therapeutics annual cash flow from investing activities is currently $4.22 million, with the most recent change of +$4.40 million (+2393.74%) on 31 December 2023. During the last 3 years, it has risen by +$4.28 million (+6576.04%). QLGN annual CFI is now at all-time high.QLGN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$1.25 M
-$1.60 M-457.14%
30 September 2024
Summary:
Qualigen Therapeutics quarterly cash flow from investing activities is currently -$1.25 million, with the most recent change of -$1.60 million (-457.14%) on 30 September 2024. Over the past year, it has dropped by -$5.48 million (-129.57%). QLGN quarterly CFI is now -129.57% below its all-time high of $4.23 million, reached on 30 September 2023.QLGN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$664.60 K
-$5.48 M-113.81%
30 September 2024
Summary:
Qualigen Therapeutics TTM cash flow from investing activities is currently -$664.60 thousand, with the most recent change of -$5.48 million (-113.81%) on 30 September 2024. Over the past year, it has dropped by -$4.40 million (-117.79%). QLGN TTM CFI is now -113.81% below its all-time high of $4.81 million, reached on 30 June 2024.QLGN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2393.7% | -129.6% | -117.8% |
| 3 y3 years | +6576.0% | -10000.0% | -434.2% |
| 5 y5 years | - | -6150.0% | -616.2% |
QLGN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2393.7% | -129.6% | at low | -113.8% | at low |
| 5 y | 5 years | at high | +2267.6% | -129.6% | at low | -113.8% | at low |
| alltime | all time | at high | +2267.6% | -129.6% | at low | -113.8% | at low |
Qualigen Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.25 M(-457.1%) | -$664.60 K(-113.8%) |
| June 2024 | - | $350.00 K(>+9900.0%) | $4.81 M(+9.0%) |
| Mar 2024 | - | $0.00(-100.0%) | $4.41 M(+4.7%) |
| Dec 2023 | $4.22 M(-2393.7%) | $235.40 K(-94.4%) | $4.22 M(+12.8%) |
| Sept 2023 | - | $4.23 M(-8833.5%) | $3.74 M(-844.1%) |
| June 2023 | - | -$48.40 K(-75.6%) | -$502.10 K(+51.1%) |
| Mar 2023 | - | -$198.00 K(-19.0%) | -$332.20 K(+80.7%) |
| Dec 2022 | -$183.80 K | -$244.40 K(+2062.8%) | -$183.80 K(-521.6%) |
| Sept 2022 | - | -$11.30 K(-109.3%) | $43.60 K(-3.5%) |
| June 2022 | - | $121.50 K(-345.0%) | $45.20 K(-137.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$49.60 K(+191.8%) | -$122.00 K(-13.7%) |
| Dec 2021 | -$141.40 K(+117.2%) | -$17.00 K(+75.3%) | -$141.40 K(+13.7%) |
| Sept 2021 | - | -$9700.00(-78.8%) | -$124.40 K(-58.8%) |
| June 2021 | - | -$45.70 K(-33.8%) | -$301.70 K(-53.8%) |
| Mar 2021 | - | -$69.00 K(-63.1%) | -$653.70 K(+11.8%) |
| Dec 2020 | -$65.10 K(-66.5%) | - | - |
| Sept 2020 | - | -$187.00 K(-53.0%) | -$584.70 K(+40.0%) |
| June 2020 | - | -$397.70 K(+1888.5%) | -$417.70 K(+350.1%) |
| Mar 2020 | -$194.50 K | - | - |
| Sept 2019 | - | -$20.00 K(-72.5%) | -$92.80 K(+27.5%) |
| June 2019 | - | -$72.80 K | -$72.80 K |
FAQ
- What is Qualigen Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual CFI year-on-year change?
- What is Qualigen Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly CFI year-on-year change?
- What is Qualigen Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Qualigen Therapeutics?
- What is Qualigen Therapeutics TTM CFI year-on-year change?
What is Qualigen Therapeutics annual cash flow from investing activities?
The current annual CFI of QLGN is $4.22 M
What is the all time high annual CFI for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual cash flow from investing activities is $4.22 M
What is Qualigen Therapeutics annual CFI year-on-year change?
Over the past year, QLGN annual cash flow from investing activities has changed by +$4.40 M (+2393.74%)
What is Qualigen Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of QLGN is -$1.25 M
What is the all time high quarterly CFI for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly cash flow from investing activities is $4.23 M
What is Qualigen Therapeutics quarterly CFI year-on-year change?
Over the past year, QLGN quarterly cash flow from investing activities has changed by -$5.48 M (-129.57%)
What is Qualigen Therapeutics TTM cash flow from investing activities?
The current TTM CFI of QLGN is -$664.60 K
What is the all time high TTM CFI for Qualigen Therapeutics?
Qualigen Therapeutics all-time high TTM cash flow from investing activities is $4.81 M
What is Qualigen Therapeutics TTM CFI year-on-year change?
Over the past year, QLGN TTM cash flow from investing activities has changed by -$4.40 M (-117.79%)